![Christian Henrik Tange](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christian Henrik Tange
Directeur Général chez
PHARMA EQUITY GROUP A/S
Profil
Christian Henrik Tange currently works at Reponex Pharmaceuticals A, as Chief Executive Officer, Pharma Equity Group A, as Chief Executive Officer from 2025, and KDev Investments AB, as Director.
Mr. Tange also formerly worked at Dilafor AB, as Chairman, Promimic AB, as Director, Xspray Pharma AB, as Director, KDev Oncology AB, as Director, Karolinska Development AB (Private Equity), as Chief Financial Officer from 2014 to 2017, AGC Biologics A, as Chief Financial Officer, Agillic A, as Chief Financial Officer from 2018 to 2020, KDventures AB, as Chief Financial Officer from 2014 to 2017, and Warner Lambert Nordic AB, as Business Controller.
Mr. Tange received his undergraduate degree and graduate degree from Copenhagen Business School.
Postes actifs de Christian Henrik Tange
| Sociétés | Poste | Début |
|---|---|---|
| PHARMA EQUITY GROUP A/S | Directeur Général | 01/04/2025 |
KDev Investments AB
 KDev Investments AB BiotechnologyHealth Technology Engages in research, sales, and development in the fields of medicine and owns and manages investments | Directeur/Membre du Conseil | - |
Reponex Pharmaceuticals A/S
 Reponex Pharmaceuticals A/S BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Directeur Général | - |
Anciens postes connus de Christian Henrik Tange
| Sociétés | Poste | Fin |
|---|---|---|
| AGILLIC A/S | Directeur Financier/CFO | 01/09/2020 |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development seeks investment in companies located in the Nordic region, primarily in Swedish. The firm targets companies operating in the fields of health technology, health services, medical devices, technology services, life science. It provides financing for early stage capital requirements. It takes a seat on the board of directors. | Directeur Financier/CFO | 30/11/2017 |
| KDVENTURES AB | Directeur Financier/CFO | 29/08/2017 |
AGC Biologics A/S
 AGC Biologics A/S Pharmaceuticals: MajorHealth Technology Operates as a global contract process development and manufacturer of biopharmaceuticals | Directeur Financier/CFO | - |
Warner Lambert Nordic AB | Corporate Officer/Principal | - |
Formation de Christian Henrik Tange
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
36
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Pharma Equity Group A/S
 Pharma Equity Group A/S Pharmaceuticals: MajorHealth Technology Functions as an investment holding company whose subsidiary develops bacterial peritonitis, chronic skin ulcers, inflammatory bowel and cancer biopharmaceuticals | Health Technology |
Copenhagen Business School
 Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karolinska Development AB (Private Equity)
Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development seeks investment in companies located in the Nordic region, primarily in Swedish. The firm targets companies operating in the fields of health technology, health services, medical devices, technology services, life science. It provides financing for early stage capital requirements. It takes a seat on the board of directors. | Finance |
AGC Biologics A/S
AGC Biologics A/S Pharmaceuticals: MajorHealth Technology Operates as a global contract process development and manufacturer of biopharmaceuticals | Health Technology |
Agillic A/S
 Agillic A/S Packaged SoftwareTechnology Services Develops software for marketing and campaign management solutions | Technology Services |
Promimic AB
 Promimic AB Medical SpecialtiesHealth Technology Develops and markets unique coating for medical implants | Health Technology |
Dilafor AB
 Dilafor AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products from heparin derivatives | Health Technology |
Xspray Pharma AB
 Xspray Pharma AB Pharmaceuticals: MajorHealth Technology Develops and produces particulate materials for the pharmaceutical industry | Health Technology |
Karolinska Development AB
 Karolinska Development AB Financial ConglomeratesFinance Operates as a life sciences investment company | Finance |
KDev Oncology AB
 KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services Offers research and development services in the field of oncology | Commercial Services |
KDev Investments AB
KDev Investments AB BiotechnologyHealth Technology Engages in research, sales, and development in the fields of medicine and owns and manages investments | Health Technology |
Warner Lambert Nordic AB | |
Reponex Pharmaceuticals A/S
Reponex Pharmaceuticals A/S BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
